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Mitochondria undergo dynamic changes to maintain
function in eukaryotic cells. Insulin action in parallel
regulates glucose homeostasis, but whether specific
changes in mitochondrial dynamics alter insulin
action and glucose homeostasis remains elusive.
Here, we report that high-fat feeding in rodents
incurred adaptive dynamic changes in mitochondria
through an increase in mitochondrial fission in par-
allel to an activation of dynamin-related protein 1
(Drp1) in the dorsal vagal complex (DVC) of the brain.
Direct inhibition of Drp1 negated high-fat-feeding-
induced mitochondrial fission, endoplasmic reticu-
lum (ER) stress, and insulin resistance in the DVC
and subsequently restored hepatic glucose pro-
duction regulation. Conversely, molecular activation
of DVC Drp1 in healthy rodents was sufficient to
induce DVC mitochondrial fission, ER stress, and in-
sulin resistance. Together, these data illustrate that
Drp1-dependent mitochondrial fission changes in
the DVC regulate insulin action and suggest that tar-
geting the Drp1-mitochondrial-dependent pathway
in the brain may have therapeutic potential in insulin
resistance.
Mitochondria exist as dynamic organelles that undergo morpho-
logical changes in response to nutritional status. In response
to nutrient shortage, mitochondria fuse to form elongated
mitochondria so as tomaximize ATP production, whereas during
nutrient excess, they undergo fission to form smaller, frag-
mented mitochondrion, in order to prevent overt ATP synthesis
(Mishra and Chan, 2016). Whereas mitofusin 1 and 2 and optic
atrophy 1 are regulators of mitochondria fusion, the canonical
mechanism of mitochondria fission is dependent on the dyna-Cell R
This is an open access article under the CC BY-Nmin-like protein, Drp1 (Mishra and Chan, 2016; Youle and van
der Bliek, 2012). The role of mitochondrial dynamics in regu-
lating cellular energy metabolism has been extensively studied,
where changes in specific mitochondrial dynamic events have
been implicated to alter cellular and whole-body homeostatic
action of insulin.
For example, alteration of mitochondrial b-oxidation (Befroy
et al., 2007) and density (Kelley et al., 2002; Morino et al.,
2005) are associated with muscle insulin resistance in humans,
whereas obese rodents and humans exhibit smaller mitochon-
dria in the skeletal muscle (Jheng et al., 2012; Kelley et al.,
2002). One study reports an increase in Drp1-dependent mito-
chondrial fission in the muscle associated with insulin resistance
in rodents (Jheng et al., 2012) and another demonstrates that
liver-specific mitofusin 2 knockdown mice are hepatic insulin
resistant and glucose intolerant (Sebastia´n et al., 2012). Although
the overall and relative contribution of mitochondrial fission and
fusion in insulin resistance in rodents and humans is of emerging
interest, it remains unclear whether changes in mitochondrial
dynamism affect brain insulin action and consequently whole-
body glucose regulation in vivo.
In this regard, insulin action in the hypothalamus and the
dorsal vagal complex (DVC) of the brain lowers hepatic glucose
production in healthy rodents but, when subjected to high-fat
feeding as short as 3 days, is disrupted in both the brain regions
(Filippi et al., 2012; Ono et al., 2008; Pocai et al., 2005). Activation
of S6 kinase in parallel to an increase in hypothalamic inflamma-
tion is implicated in diet-induced hypothalamic insulin resistance
(Ono et al., 2008; Thaler et al., 2012; Zhang et al., 2008). In the
DVC, however, the potential mechanistic link(s) between high-
fat feeding and insulin resistance remain elusive. Characterizing
DVC insulin resistance warrants an urgent necessity, especially
in light of the clinical findings that intranasal insulin delivery,
which would target the hypothalamus and DVC, improves insulin
sensitivity and lowers glucose production in healthy, but not
obese, humans (Dash et al., 2015; Heni et al., 2014). We here
focused on dissecting DVC insulin resistance in rodents andeports 18, 2301–2309, March 7, 2017 ª 2017 The Author(s). 2301
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. HFD Induces Mitochondrial Fission and Insulin Resistance in the DVC via Drp1
(A) Schematic representation of the working hypothesis.
(B) Representative electron microscopy images of mitochondria in the somatic regions of the DVC taken from RC, 3-day HFD, and 3-day HFD + DVC MDIVI-1-
treated rats. The scale bar represents 2 mm; black arrow, rough endoplasmic reticulum; corner red square inset, enlarged image of mitochondria from the smaller
red-boxed area; nu, nucleus.
(C) Mitochondria density from RC (144 mitochondria from nine neurons), 3-day HFD (287 mitochondria from eight neurons), and 3-day HFD+ DVC MDIVI-1 (104
mitochondria from six neurons)-treated rats.
(D) Aspect ratio from RC (141 mitochondria from nine neurons), 3-day HFD (238 mitochondria from eight neurons), and 3-day HFD+ DVC MDIVI-1 (97 mito-
chondria from six neurons)-treated rats.
(E) Form factor from RC (75 mitochondria from nine neurons), 3-day HFD (75 mitochondria from eight neurons), and 3-day HFD+ DVC MDIVI-1 (75 mitochondria
from six neurons)-treated rats.
(F) Glucose infusion rate during the clamps.
(G) Glucose production in basal (white square) and clamp (black square) conditions.
n = 6 for saline RC rats, n = 8 for insulin RC rats, n = 5 for MDIVI-1+ saline RC rats, n = 5 for MDIVI-1 + insulin RC rats, n = 7 for saline HFD rats, n = 10 for insulin
HFD rats, n = 4 for MDIVI-1 + saline HFD rats, and n = 7 for insulin + MDIVI-1 HFD rats. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Values are shown as
mean + SEM.
(H) p-Drp1 levels (normalized to total-Drp1) in the DVC of RC (n = 16), HFD (n = 16), MDIVI-1 + HFD (n = 12), and MDIVI-1 + RC (n = 6) rats; representative western
blot image pasted below.
See also Figure S1 and Tables S1 and S2.hypothesize that changes inmitochondria dynamics play a caus-
ative role in DVC insulin resistance (Figure 1A).
RESULTS
High-Fat Feeding Induces DVC Mitochondrial Fission
and Insulin Resistance via Drp1
We obtained cross-sectional slides containing the DVC from rats
fed a 3-day high-fat diet (HFD) or regular chow (RC) (Figure S1A).2302 Cell Reports 18, 2301–2309, March 7, 2017Electron microscopy imaging in the somatic portions (Figure 1B)
of DVC neuronal cells indicated that HFD versus RC increased
the number of mitochondria in the neuronal soma (reflected
by increased density of mitochondria per cell area; Figure 1C).
These mitochondria were less elongated and elliptical (reflected
by decreased aspect ratio; Figure 1D) and were shorter and less
branched (reflected by decreased form factor; Figure 1E).
Notably, no such differences in the mitochondrial density and
morphology were observed in the dendritic compartments of
DVC neurons between HFD versus RC rats (Figures S1C–S1F).
Given that the observed mitochondrial changes in the DVC
neuronal cell bodies could either be due to an increase in fission
or a decrease in fusion, we chose to first examine the role of the
fission protein Drp1 in this process.
We inhibited DVC Drp1 via DVC infusion of Drp1 inhibitor
MDIVI-1, which blocks Drp1 translocation from the cytosol
to the mitochondria (Cassidy-Stone et al., 2008). The daily
DVC MDIVI-1 infusion was administered 1 day after the initiation
of HFD and maintained for 3 days (Figure S1A). Infusion of
MDIVI-1 during HFD reversed the HFD-induced changes in the
somatic mitochondrial morphology (Figure 1B) as the mitochon-
dria density (Figure 1C), aspect ratio (Figure 1D), and form factor
(Figure 1E) were normalized back to RC levels. The mitochondria
in the dendrites remained unaffected by MDIVI-1 (Figures S1C–
S1F). Thus, HFD alters Drp1 to induce mitochondrial fission in
the DVC and raises the possibility that Drp1-dependent mito-
chondrial fission is necessary for HFD-induced DVC insulin
resistance.
To address this, we first confirmed that infusion of insulin
versus saline into the DVC of healthy rats increased exogenous
glucose infusion rate (Figure 1F) needed to maintain euglycemia
(Table S1) under pancreatic-(basal insulin) clamp conditions
(Table S2; Figure S1B). The elevation in glucose infusion rate
induced by DVC insulin infusion was due to an inhibition of
glucose production (Figures 1G and S1G) and not an increase
in glucose uptake (Figure S1H). The gluco-regulatory effect of
DVC insulin was abolished in 3-day HFD rats (Figures 1F, 1G,
S1G, and S1H; Tables S1 and S2), consistent with the previous
report that HFD induces DVC insulin resistance (Filippi et al.,
2012). Importantly, we here discovered that co-infusion of insulin
withMDIVI-1 into the DVC, at a dose thatMDIVI-1 negated 3-day
HFD to increase mitochondrial fission (Figures 1B–1E), also
restored DVC insulin to regulate glucose kinetics and specifically
in lowering glucose production in 3-day HFD rats (Figures 1F,
1G, S1G, and S1H; Tables S1 and S2). In parallel, DVC MDIVI-1
infusion did not alter glucose regulation while insulin is infused
into the DVC of RC-fed rats as compared to insulin alone (Figures
1F, 1G, S1G, and S1H; Table S1). These data indicate that inhib-
iting DVC Drp1-dependent mitochondrial fission selectively
restores the ability of insulin to lower glucose production dur-
ing HFD and demonstrate that Drp1-dependent mitochondrial
fission in the DVC is necessary to induce brain insulin resistance.
To confirm HFD changes in Drp1, we next assessed the phos-
phorylation of Drp1 in the DVC of 3-day HFD rats and found a
reduction of phosphorylated Drp1 (p-Drp1) in the residue S637
induced by HFD versus RC (Figure 1H). A decrease in pDrp1
(S637) increases Drp1 activity (Chang and Blackstone, 2007),
thereby indicating that HFD activates DVC Drp1. DVC MDIVI-1
infusion normalized the reduced DVC p-Drp1 levels in HFD
rats, comparable to RC (Figure 1H), whereas DVC MDIVI-1 infu-
sion in RC rats increased p-Drp1 levels compared to RC without
MDIVI-1 (Figure 1H).
Molecular Inhibition of Drp1 Reverses Mitochondrial
Fission and HFD-Induced DVC Insulin Resistance
We next tested the effects of an adenoviral-mediated molecular
inhibition of Drp1 in reversing HFD-induced DVC insulin resis-tance. The adenoviral construct was driven by a cytomegalovirus
(CMV) promoter expressing a FLAG-tagged dominant-negative
form of Drp1 (Drp1 K38 to A [Drp1-KA]). The Drp1-KA lacks
the guanosine triphosphate (GTP) binding site required for
Drp1 (a GTPase) to carry out its mitochondrial fission activity.
Although this approach was used to block Drp1 in in vitro and
in vivomodels (Qi et al., 2013; Rappold et al., 2014), in the current
study, we first validated the virus in HEK293 cells and eval-
uated for potential changes in Drp1 localization and mitochon-
drial morphology in infected cells using confocal microscopy.
Whereas mitochondrial translocation of Drp1 is a hallmark of
mitochondrial fission, our co-localization analysis revealed that
Drp1-KA-FLAG expression negatively correlated with mitochon-
drial staining in HEK293 cells, much less than the random co-
localization observed for the GFP controls with mitochondria
(Figure 2A), thereby indicating that the KA mutation indeed
blocked Drp1 translocation to the mitochondria. Using z stack
images, we then constructed a 3D model of individual cells
(Movie S1) that were infected with Drp1-KA or GFP and found
that Drp1-KA versus GFP reduced the number of mitochondria
(Movie S1; Figure 2B) and altered mitochondria morphology
indicated by an in increase in aspect ratio (Figure 2C) and an in-
crease in average mitochondria volume (Figure 2D). Thus, the
overall effect of Drp1-KA expression was indeed an inhibition
in mitochondrial fission.
We then injected the Drp1-KA-FLAG or GFP control virus into
the DVC of HFD rats to examine whether Drp1-KA would alle-
viate DVC insulin resistance. We validated that Drp1-KA-FLAG
was expressed only in the DVC, but not in the neighboring brain
regions (Figures S2A and S2B), and evaluated the effect of
Drp1-KA versus GFP on DVC insulin action during pancreatic
clamps in 3-day HFD-fed rats (Figure S1B). DVC insulin infusion
failed to increase glucose infusion rate and lower glucose pro-
duction in GFP-injected HFD versus RC-fed rats (Figures 2E,
2F, and S2C). Consistent with the effects of MDIVI-1, Drp1-KA
injection in rats was also protective against HFD-induced DVC
insulin resistance in restoring the ability of DVC insulin to in-
crease glucose infusion rate and lower glucose production (Fig-
ures 2E, 2F, and S2C). Drp1-KA did not alter insulin action in RC
rats (Figures 2E, 2F, and S2C), and glucose uptake was compa-
rable among groups (Figure S2D). Thus, DVC-targeted inhibition
of Drp1 reverses HFD-induced insulin resistance.
Molecular Activation of Drp1 Induces Mitochondrial
Fission and DVC Insulin Resistance
We evaluated whether activation of Drp1 per se was sufficient to
induce insulin resistance. We generated an adenovirus driven by
a CMV promoter expressing a FLAG-tagged phospho-deficient
mutant of Drp1 (Drp1 S637 to A [Drp1-SA]), which is constitu-
tively active, as a decrease in pDrp1 (S637) increases Drp1 activ-
ity (Chang and Blackstone, 2007). Using confocal microscopy,
we assessed the potential co-localization between Drp1-SA-
FLAG or GFP and mitochondria and evaluated for changes in
mitochondria morphology in individual infected cells. We discov-
ered that Drp1-SA-FLAG infection overlapped and positively
correlated with some mitochondria in HEK293 cells compared
to the random co-localization of control GFP with mitochondria
in cells based on dual-color imaging (Figure 3A). Using z stackCell Reports 18, 2301–2309, March 7, 2017 2303
Figure 2. Drp1-KA Expression on Mitochondria Dynamics and Insulin Action
(A) Representative confocal microscopy images of HEK293 cells expressing GFP or Drp1-KA-FLAG (green). Mitochondria are stained with Mitotracker Red (red),
and overlay images are shown. The scale bar represents 10 mm. The dashed white line on the merged image represents the analyzed region as shown to the right
(0–15 mm). The line profiles indicate the intensity of Mitotracker Red and the GFP or Drp1-KA-FLAG. Pearson’s correlation coefficient analysis is presented from
66 cells for GFP and 43 cells for Drp1-KA-FLAG.
(B) Number of mitochondria per cell.
(C) Aspect ratio of mitochondria.
(D) Average volume of mitochondria.
(B–D) Eighty-one cells for GFP and 81 cells for Drp1-KA were analyzed obtained from three independent experiments.
(E) Glucose infusion rate during the clamps of adenoviral-DVC-infected rats.
(F) Glucose production in basal (white square) and clamp (black square) conditions.
n = 6 for salineGFPRC, n = 10 for insulin GFPRC, n = 5 for saline Drp1-KARC, n = 5 for insulin Drp1-KARC, n = 6 for salineGFPHFD, n = 5 for insulin GFPHFD, n = 5
salineDrp1-KAHFDandn=5 for insulinDrp1-KAHFDrats. **p<0.01; ***p<0.001; ****p<0.0001.Valuesare shownasmean+SEM.SeealsoFigureS2andMovieS1.images, we then constructed the 3D model of individual cells
(Movie S2) that were infected with Drp1-SA or GFP and found
that Drp1-SA increased the number of mitochondria (Movie S2;
Figure 3B) and altered mitochondria morphology indicated by
a reduction in aspect ratio (Movie S2; Figure 3C) and mean mito-
chondrial volume (Movie S2; Figure 3D). The overall effect of
Drp1-SA is an increase in mitochondrial fission.
We next injected the adenovirus expressing Drp1-SA-FLAG or
GFP into the DVC of RC rats (Figure S1B). Localization studies
confirmed that Drp1-SA-FLAG was selectively expressed in
the DVC, but not in the adjacent regions (Figures S2A and S2E)
of the same rats. We then evaluated the effect of Drp1-SA versus
GFP on insulin action in RC rats (Figure S1B) and found that,2304 Cell Reports 18, 2301–2309, March 7, 2017although DVC insulin infusion in GFP rats was still able to in-
crease glucose infusion rate to maintain euglycemia (Figure 3E)
and lower glucose production (Figures 3F and S2F) with no
changes in glucose uptake (Figure S2G), DVC insulin infusion
failed to alter glucose kinetics in Drp1-SA rats (Figures 3E, 3F,
S2F, and S2G). Hence, molecular activation of Drp1-dependent
mitochondria in the DVC was sufficient to induce insulin resis-
tance and recapitulate the effect of HFD.
Drp1-Dependent Mitochondrial Fission Enhances ER-
Stress-Dependent Insulin Resistance in the DVC
Drp1-dependent mitochondrial fission in the pancreatic b cells
elevates endoplasmic reticulum (ER) stress (Peng et al., 2011)
Figure 3. Drp1-SA Expression on Mitochondria Dynamics and Insulin Action
(A) Representative confocal microscopy images of HEK293 cells expressing GFP or Drp1-SA-FLAG (green). Mitochondria are stained with Mitotracker Red (red),
and overlay images are shown. The scale bar represents 10 mm. The dashed white line on the merged image represents the analyzed region as shown to the right
(0–15 mm). The line profiles indicate the intensity of Mitotracker Red and the GFP or Drp1-SA-FLAG. Overlapping region is indicated by an arrow. Pearson’s
correlation coefficient analysis is presented from 60 cells for GFP and 55 cells for Drp1-SA-FLAG.
(B) Number of mitochondria per cell.
(C) Aspect ratio of mitochondria.
(D) Average volume of mitochondria.
(B–D) Eighty-nine cells for GFP and 83 cells for Drp1-SA were analyzed and obtained from three independent experiments.
(E) Glucose infusion rate during the clamps of adenoviral-DVC-infected rats.
(F) Glucose production in basal (white square) and clamp (black square) conditions.
n = 5 for saline GFP rats, n = 6 for insulin GFP rats, saline Drp1-SA rats, and insulin Drp1-SA rats. *p < 0.05; **p < 0.01; ***p < 0.001. Values are shown as mean +
SEM. See also Figure S2 and Movie S2.and mediates fatty-acid-induced ER expansion (Wikstrom et al.,
2013). In parallel, elevated ER stress induces hepatic (Yang et al.,
2015) and hypothalamic insulin resistance (Zhang et al., 2008).
Thus, we here evaluated whether ER stress mediates the ability
of HFD-induced Drp1-dependent mitochondria changes in the
DVC to impair insulin action (Figure 4A). We first found that
3-day HFD versus RC increased ER stress marker p-PERK
(T980) in the DVC (Figures 4B and S1A). This effect of HFD on
p-PERK was negated by DVC ER stress inhibitor 4-phenylbuty-
rate (4-PBA) infusion (Figure 4B) and recapitulated by DVC ER
stress inducer tunicamycin (TM) administration (Figures 4C and
S1A). Co-infusion of 4-PBA with insulin into the DVC of 3-day
HFD rats restored the ability of DVC insulin to increase glucose
infusion rate (Figure 4D) and lower glucose production (Figure 4E)
to a comparable extent as DVC insulin-infused RC rats (Figures
4D and 4E), whereas DVC 4-PBA infusion alone did not alter
glucose kinetics (Figures 4D and 4E). Conversely, DVC TM infu-sion was sufficient to induce DVC insulin resistance (Figures 4D
and 4E) but, when infused alone without insulin, did not alter
glucose kinetics (Figures 4D and 4E). Glucose uptake was com-
parable among groups (Figure S3A). Thus, ER stress in the DVC
is necessary for HFD and sufficient to induce insulin resistance.
We evaluated whether ER stress is necessary for mitochon-
drial fission to induce insulin resistance (Figure 4A). We first
found that DVC 4-PBA infusion failed to prevent the ability of
HFD to decrease p-Drp1 (or activate Drp1; Figures 4F and
S1A), whereas DVC MDIVI-1 infusion negated the ability of
HFD to increase p-PERK (Figure 4G). Together with the fact
that DVC 4-PBA negated HFD to increase ER stress (Figure 4B)
and DVC MDIVI-1 prevented HFD-induced mitochondrial fission
(Figures 1B–1E), these data demonstrate that ER stress is a
downstream effector of HFD-induced Drp1-dependent mito-
chondrial fission in the DVC. Consistently, activation of Drp1-
dependent mitochondrial fission in the DVC via DVC Drp1-SACell Reports 18, 2301–2309, March 7, 2017 2305
Figure 4. Drp1-Mitochondrial Fission Enhances ER-Stress-Dependent DVC Insulin Resistance
(A) Schematic representation of the working hypothesis.
(B and C) DVC ER-stress marker PERK phosphorylation (T980) levels were analyzed and normalized to total PERK with representative western blot image pasted
below. n = 5 for RC and HFD and n = 6 for HFD + 4-PBA rats (B); n = 12 for RC and n = 6 for TM rats (C).
(D) Glucose infusion rate during the clamp.
(E) Glucose production suppression expressed as the percentage reduction from basal (60–90min) to clamp (final 30 min) conditions. n = 6 for saline RC, n = 8 for
insulin RC, n = 7 for saline HFD, n = 10 for insulin HFD, n = 5 for 4-PBA + saline or 4-PBA + insulin HFD, n = 6 for saline + TM RC, and n = 5 for RC insulin + TM rats.
(F) p-Drp1 levels (normalized to total-Drp1) in the DVC of RC (n = 5), HFD (n = 6), and HFD + 4-PBA (n = 6) rats with representative western blot image pasted
below.
(G and H) DVC ER-stressmarker PERK phosphorylation (T980) levels were analyzed and normalized to total PERKwith representative western blot image pasted
below. n = 9 for RC, n = 14 for HFD, and n = 13 for HFD + MDIVI-1 rats (G); n = 5 for GFP, n = 4 for Drp1-SA, and n = 5 for Drp1-SA+ 4-PBA rats (H).
(I) Glucose infusion rate during the clamps of adenoviral-DVC-infected rats.
(J) Glucose production suppression expressed as the percentage reduction from basal (60–90 min) to clamp (final 30 min) conditions.
n = 6 for saline GFP, n = 6 for insulin GFP, n = 6 for saline Drp1-SA or insulin Drp1-SA or insulin + 4-PBA-Drp1-SA rats, and n = 5 for saline + 4-PBA-Drp1-SA rats.
*p < 0.05; **p < 0.01; ***p < 0.001. Values are shown as mean + SEM. See also Figure S3.
2306 Cell Reports 18, 2301–2309, March 7, 2017
injection induced ER stress (Figure 4H) and insulin resistance
(Figures 4I and 4J) in RC rats. DVC 4-PBA infusion in Drp1-SA
rats reduced ER stress (Figures 4H and S1A) and restored
the ability of DVC insulin infusion to increase glucose infusion
rate (Figure 4I) and lower glucose production (Figure 4J) with
no changes on glucose uptake (Figure S3B). DVC 4-PBA infusion
alone, independent of insulin co-infusion, did not alter glucose
kinetics in DVC Drp1-SA rats (Figures 4I, 4J, and S3B). Thus,
HFD-induced DVC Drp1-dependent mitochondrial fission ele-
vates ER stress and subsequently induces insulin resistance.
An induction of inducible nitric oxide synthase (iNOS) expres-
sion in the muscle by HFD induces insulin resistance (Perreault
andMarette, 2001) and, in the liver, mediates HFD-induced S-ni-
trosylation to elevate ER stress and impair insulin signaling (Yang
et al., 2015). An activation of Drp1-dependent mitochondrial
fission by lipopolysaccharide elevates iNOS in microglial cells
as well (Park et al., 2013). This led us to hypothesize that an
increase in iNOS could mediate the ability of Drp1-dependent
mitochondrial fission to induce insulin resistance. To begin
addressing this possibility, we first infected PC12 cells with the
Drp1-SA-FLAG virus that induced ER stress (Figure 4H) and in-
sulin resistance (Figures 4I and 4J) and found that Drp1-SA
versus GFP increased iNOS (Figure S4A). Moreover, Drp1-SA
versus GFP viral injection into the DVC of RC rats also increased
DVC iNOS expression (Figure S4B). In parallel, 3-day HFD
increased DVC iNOS expression (Figure S4C) and such effect
was negated by DVC MDIVI-1 (Figure S4C). These findings pre-
liminarily indicate that Drp1-dependent mitochondrial fission is
necessary for HFD and sufficient to increase iNOS expression.
Together with the fact that ER stress is required for elevated
iNOS expression in the liver to induce insulin resistance (Yang
et al., 2015) and for Drp1-dependent mitochondrial fission in
the DVC to induce insulin resistance (Figures 4I and 4J), we
put forward a working hypothesis that an iNOS-ER stress axis
in the brain is necessary for HFD-induced Drp1-dependent mito-
chondrial fission to induce insulin resistance.
The insulin signaling pathway is negatively regulated by serine
phosphorylation of insulin receptor substrate (IRS) (Copps and
White, 2012). In addition, mitochondria dysfunction and ER
stress have been linked to an increase in serine IRS1 phosphor-
ylation in muscle and liver (Morino et al., 2005; Ozcan et al.,
2004). To finally assess whether HFD-induced DVCDrp1-depen-
dent mitochondrial fission impairs insulin action, we assessed
the serine phosphorylation status of IRS1 in the DVC in HFD
rats. We discovered that 3-day HFD increased phosphorylation
of IRS1 Ser-1101 (IRS1-p-S1101) (Figure S4D), consistent with
the fact that hepatic IRS1-p-S1101 is elevated in obese rodents
(Tremblay et al., 2007). DVC MDIVI-1 infusion in 3-day HFD rats
that inhibited Drp1-dependent mitochondrial fission (Figures
1B–1E), iNOS expression (Figure S4C), and ER stress (Figure 4G)
also negated the ability of HFD to increase IRS1-p-S1101 (Fig-
ure S4D), confirming that an increase in DVC mitochondrial
fission induces insulin resistance.
DISCUSSION
Our discoveries indicate that activation of Drp1-mitochondrial
fission in the DVC is sufficient and necessary for HFD to elevateER stress and iNOS and induce insulin resistance in rodents.
Together with the fact that iNOS and ER stress mediates hepatic
and muscle insulin resistance (Perreault and Marette, 2001;
Yang et al., 2015), inhibiting whole-body Drp1 reverses muscle
insulin resistance in obese rodents (Jheng et al., 2012), and
exercise increases insulin sensitivity in association to a decrease
in muscle Drp1 in obese and insulin-resistant humans (Fealy
et al., 2014), mitochondrial fission may represent a primary and
fundamental process in insulin-sensitive organs that govern
insulin action. Nonetheless, the mechanistic and causative
sequential link of Drp1-mitochondrial fission, ER stress, and
iNOS to insulin resistance in the brain, as well as the underlying
neurocircuitry involved, warrant future investigation.
The metabolic impact of brain-specific changes in mitochon-
drial dynamics is becoming apparent as manipulation of mito-
chondria dynamics in neurons alters the progression of obesity
and metabolic status in rodents (Schneeberger et al., 2013; Die-
trich et al., 2013; Toda et al., 2016). Our current set of data not
only strengthens the claim that changes in brain mitochondrial
dynamics impact whole-body metabolic regulation but also spe-
cifically demonstrates that bi-directional changes of Drp1-mito-
chondrial fission in theDVC regulate insulin action in vivo. Further,
these findings support the notion that HFD increases mitochon-
drial fission and ER stress that leads to brain insulin and leptin
resistance (Schneeberger et al., 2013; Zhang et al., 2008).
How high-fat feeding affects mitochondrial fission in the
somatic portions of neurons versus dendrites is yet to be
answered. Interestingly, studies from the Alzheimer’s disease
field report that mitochondrial fission/fusion proteins and other
mitochondrial membrane proteins, such as COX1 and mtDNA,
show a pattern of redistribution away from neuronal processes
to only soma in the hippocampal neurons of a brain affected
by Alzheimer’s (Wang et al., 2009). The distinct neuronal popula-
tions involved in displaying the HFD-induced changes in mito-
chondria fission, and possibly redistribution to soma in the
DVC to induce insulin resistance, remain largely unknown and
an important future research direction.
Our findings also open the question of howDrp1 is activated in
response to HFD. We hypothesize that serine threonine phos-
phatase calcineurin, which dephosphorylates Drp1 S637, may
be the mediator as calcineurin increases Drp-mitochondrial
fission during ischemia-reperfusion injury in cardiomyocytes
(Sharp et al., 2014), whereas increased calcineurin activity in
neurons mediate mitochondrial translocation of Drp1 and cause
mitochondrial fragmentation in Huntington’s disease (Costa
et al., 2010). Further, a knockdown of muscle calcineurin hyper-
phosphorylated Drp1 and increased mitochondrial elongation
(Pfluger et al., 2015). Whether DVC calcineurin ablation would
prevent the HFD-induced decrease in p-Drp1 levels, increase
in mitochondrial fission, and induction of insulin resistance
merits future investigation. In parallel, AMPK activation is linked
to mitochondrial fission (Toyama et al., 2016). Given that an inhi-
bition of hypothalamic AMPK lowers glucose production (Yang
et al., 2010), we postulate that an AMPK-Drp1-dependent mito-
chondrial fission in the DVC regulates insulin action. In summary,
we postulate that targeting the Drp1-mitochondria-dependent
pathways in the brain may carry therapeutic potential to reverse
insulin resistance in metabolic disorders.Cell Reports 18, 2301–2309, March 7, 2017 2307
EXPERIMENTAL PROCEDURES
All study protocols were approved by the UHN Animal Care and Use
Committee.
Animal Preparation
Eight-week-old male Sprague-Dawley (SD) rats weighing between 260 and
280 g (Charles River Laboratories) were used. Rats were housed in individual
cages andmaintained on a standard light-dark cycle with access to chow (RC)
diet and water ad libitum.
In one set of experiments (Figure S1A), rats were stereotactically (David Kopf
Instruments) implantedwith indwelling bilateral catheters targeting the nucleus
of the solitary tract (NTS) within the DVC (0.0 mm on occipital crest, 0.4 mm
lateral to midline, and 7.9 mm below skull surface; Filippi et al., 2012) on day
0. After 1 week of recovery, rats were given either Lard oil-enriched HFD or
RC for 3 days (Figure S1A). The diet composition for RC (3.1 kcal/g) was
18% fat, 49% carbohydrate, and 33% protein (Teklad diet 7002 from Harlan
Laboratories) or HFD (3.9 kcal/g) was 34% fat, 44% carbohydrate, and 22%
protein (modified lab with 10% lard 571R diet from TestDiet). On days 8 and
9, the HFD rats received 2 mL infusion of MDIVI-1 (100 mM) or saline. On day
10 (after a 4- to 6-hr fast), an infusion of MDIVI-1 (100 mM) or saline was given
at 0.006 mL/min for 270min into the DVC. The concentration of 100 mMMDIVI-1
was chosen based on the half maximal inhibitory concentration (IC50) of
MDIVI-1 (10 mM; Cassidy-Stone et al., 2008) and factoring into a dilution factor
when chemical inhibitors are DVC infused. The rats were then subjected to a
cardiac perfusion with a solution of 2% glutaraldehyde in 0.1 M sodium caco-
dylate buffer and received an injection of 3 mL bromophenol blue through each
side of the bilateral DVC catheter to verify the correct placement of the cathe-
ters. The DVC (see Figure S2A) was then collected and processed for electron
microscopy analysis. Alternatively, the rats were immediately sacrificed and
DVC brain region was validated via bromophenol blue and collected for west-
ern blot analysis.
Pancreatic-EuglycemicClamp, GlucoseKinetics Analysis, andBrain
Tissues Sampling
In a parallel set of studies, rats were stereotaxically implanted with indwelling
DVC. After 1 week of recovery, rats underwent intravenous catheterization
where the internal jugular vein and carotid artery were catheterized for infusion
and sampling and were placed either on RC or HFD (Figure S1B). Four days
post-intravenous catheterization, rats whose food intake and body weight
had recovered back to within 10% of baseline underwent the studies. Rats
were fasted 4–6 hr before the clamp experiments (Figure S1B). Insulin (a total
of 2.52 mU; 1.26 mU per site) or saline was infused at 0.006 mL/min (from time
0 to 210) through the DVC catheters (Filippi et al., 2012). MDIVI-1 (100 mM) or
4-PBA (5.4 mg/mL) was pre-infused at 0.006 mL/min for 1 hr (time 60) into the
DVC and infused or co-infused with insulin during the clamp. ER stress inducer
TM (0.033 mg/mL) was pre-infused at 0.006 mL/min for 4 hr before and then was
infused throughout the clamp (Figure S1B). We have validated that 4-PBA and
TM infused into the DVC bi-directionally and respectively alters p-PERK/total
PERK (Figures 4B and 4C). A primed continuous intravenous infusion of [3-3H]-
glucose (40 mCi bolus; 0.4 mCi/min) was initiated at 0 min and maintained
throughout the study to assess glucose kinetics. A pancreatic (basal insulin)-
euglycemic clamp was initiated at time 90 min and lasted until 210 min.
Somatostatin (3 mg/kg/min) was infused intravenously along with insulin
(1.2 mU/kg/min) to replace plasma insulin levels back to basal. A 25% glucose
solution was started at time 90 and periodically adjusted to maintain euglyce-
mia. Samples for the determination of [3-3H]-glucose-specific activity and in-
sulin levels were obtained at 10-min intervals. At the end of the experiments,
rats were injected with 3 mL bromophenol blue through each side of the bilat-
eral DVC catheter to verify the correct placement of the catheter for the viral
injection studies, whereas bromophenol blue was co-infusedwith chemical re-
agents for the non-viral injection studies (Figure S1B). Once the whole brain is
harvested from the anesthetized rat via decapitation, the cerebellum is lifted to
expose the caudal part of the brain (Figure S2A). Only those data for rats that
showed injection of dye within the vagal triangle (Figure S2A, i and ii) were
included. A spatula was used to extract the section of vagal triangle overlaying
the DVC (blue; Figure S2A, i and ii). In addition, sections of tissues were2308 Cell Reports 18, 2301–2309, March 7, 2017dissected out from the left (yellow) regions of the caudal brain containing
sp5 (spinal trigeminal tr.), Sp5C (spinal 5nu; caudal part), Sp5I (spinal 5nu;
interpolar), as well as from the region below the DVC (green) containing IN
(12-hypoglossal nucleus), Ro (nucleus of roller), and InM (intermedius nucleus
medulla; Figure S2A, iv–vi). Cerebellum (red; Figure S2A, i and iv–vi) and the
mediobasal hypothalamus (pink) were also taken (Figure S2A, iii) for subse-
quent western blot analysis (Figures S2B and S2E).
Electron microscopy analysis of mitochondrion, western blotting, prepara-
tion and injection of Drp1-KA and Drp1-SA adenovirus in rats, HEK293
and PC12 expression of Drp1-KA and Drp1-SA and immunofluorescence,
confocal imaging, mitochondrial morphology analysis, biochemical analysis,
and statistical methods are described in detail in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, two tables, and two movies and can be found with this article on-
line at http://dx.doi.org/10.1016/j.celrep.2017.02.035.
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